Biotransformation, or drug metabolism, is the chemical alteration of drugs within the body. This process primarily occurs in the liver and converts lipophilic drugs into more hydrophilic (water-soluble) metabolites, facilitating their excretion.
- Purpose: Introduce or expose functional groups (e.g., hydroxyl, amine, or carboxyl groups) on the drug molecule.
- Types of Reactions: Oxidation, reduction, and hydrolysis.
- Enzymes Involved: Cytochrome P450 (CYP450) enzymes are key players in oxidation reactions.
- Example: Diazepam undergoes oxidation by CYP450 enzymes to form active metabolites, such as desmethyldiazepam and oxazepam.
- Purpose: Increase the water solubility of the drug by conjugating it with hydrophilic molecules.
- Types of Reactions: Glucuronidation, sulfation, acetylation, and methylation.
- Enzymes Involved: Transferases (e.g., UDP-glucuronosyltransferase).
- Example: Morphine undergoes glucuronidation in the liver, forming morphine-6-glucuronide, which is more water-soluble and readily excreted in urine.
- Genetic Variability: Genetic polymorphisms in CYP450 enzymes can lead to variations in metabolism, affecting drug efficacy and toxicity.
- Age: Infants and the elderly often have reduced enzyme activity, leading to altered drug metabolism.
- Disease States: Liver diseases, such as cirrhosis, impair drug metabolism, leading to higher drug levels in the body.
- Drug Interactions: Some drugs can induce or inhibit CYP450 enzymes, altering the metabolism of other drugs.
- Activation of Prodrugs: Some drugs are administered in an inactive form (prodrugs) and require biotransformation to produce active metabolites. Example: Codeine is converted to morphine by CYP2D6 to exert its analgesic effects.
- Detoxification and Elimination: Biotransformation aids in drug detoxification and elimination, reducing toxicity.
- Drug-Drug Interactions: Enzyme induction or inhibition can lead to interactions, requiring dose adjustments.
- Phase I (Toxic Pathway): A small fraction of acetaminophen undergoes CYP450 oxidation to form a toxic metabolite, N-acetyl-p-benzoquinone imine (NAPQI).
- Phase II (Detoxification): NAPQI is detoxified by conjugation with glutathione. In overdose situations, glutathione is depleted, leading to liver toxicity.